Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma

Biochemical and Biophysical Research Communications

Volumn 446, Issue 1, 2014, Pages 54-60

  Xu, Yun Fei ^a   Yang, Xiao Qing ^b   Lu, Xiao Fei ^c   Guo, Sen ^a   Liu, Yi ^a   Iqbal, Mohammad ^a   Ning, Shang Lei ^a   Yang, Hui ^a   Suo, Ning ^b   Chen, Yu Xin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; Fibroblast growth factor receptor 4; Inhibitor; Prognosis; Progression

Indexed keywords

FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR RECEPTOR 4; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR MARKER;

AGED; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; ASSAY; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR INVASION; WESTERN BLOTTING;

CHOLANGIOCARCINOMA; FIBROBLAST GROWTH FACTOR RECEPTOR 4; INHIBITOR; PROGNOSIS; PROGRESSION;

AGED; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HEP G2 CELLS; HUMANS; IMIDAZOLES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PYRIDAZINES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898010934     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.050     Document Type: Article

References (28)

1. J.E. Everhart, and C.E. Ruhl Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas Gastroenterology 136 2009 1134 1144
2. S.A. Khan, H.C. Thomas, B.R. Davidson, and S.D. Taylor-Robinson Cholangiocarcinoma Lancet 366 2005 1303 1314
3. O. Farges, D. Fuks, Y.P. Le Treut, D. Azoulay, A. Laurent, P. Bachellier, G. Nuzzo, J. Belghiti, F.R. Pruvot, and J.M. Regimbeau AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group Cancer 117 2011 2170 2177
4. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
5. M.L. DeOliveira, S.C. Cunningham, J.L. Cameron, F. Kamangar, J.M. Winter, K.D. Lillemoe, M.A. Choti, C.J. Yeo, and R.D. Schulick Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann. Surg. 245 2007 755 762
6. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA Cancer J. Clin. 60 2010 2010 277 300
7. P.C. de Groen, G.J. Gores, N.F. LaRusso, L.L. Gunderson, and D.M. Nagorney Biliary tract cancers N. Engl. J. Med. 341 1999 1368 1378
8. T.P. Wade, C.N. Prasad, K.S. Virgo, and F.E. Johnson Experience with distal bile duct cancers in US Veterans Affairs hospitals: 1987-1991 J. Surg. Oncol. 64 1997 242 245
9. A.M. Horgan, E. Amir, T. Walter, and J.J. Knox Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis J. Clin. Oncol. 30 2012 1934 1940
10. C.D. Anderson, C.W. Pinson, J. Berlin, and R.S. Chari Diagnosis and treatment of cholangiocarcinoma Oncologist 9 2004 43 57
11. A.E. Sirica Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy Hepatology 41 2005 5 15
12. N. Turner, and R. Grose Fibroblast growth factor signalling: from development to cancer Nat. Rev. Cancer 10 2010 116 129
13. M. Wiedemann, and B. Trueb Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors Genomics 69 2000 275 279
14. V. Knights, and S.J. Cook De-regulated FGF receptors as therapeutic targets in cancer Pharmacol. Ther. 125 2010 105 117
15. E.M. Haugsten, A. Wiedlocha, S. Olsnes, and J. Wesche Roles of fibroblast growth factor receptors in carcinogenesis Mol. Cancer Res. 8 2010 1439 1452
16. Y.W. Ye, Y. Zhou, L. Yuan, C.M. Wang, C.Y. Du, X.Y. Zhou, B.Q. Zheng, X. Cao, M.H. Sun, H. Fu, and Y.Q. Shi Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression Cancer 117 2011 5304 5313
17. N. Sugiyama, M. Varjosalo, P. Meller, J. Lohi, M. Hyytiainen, S. Kilpinen, O. Kallioniemi, S. Ingvarsen, L.H. Engelholm, J. Taipale, K. Alitalo, J. Keski-Oja, and K. Lehti Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation Cancer Res. 70 2010 7851 7861
18. J.G.t. Taylor, A.T. Cheuk, P.S. Tsang, J.Y. Chung, Y.K. Song, K. Desai, Y. Yu, Q.R. Chen, K. Shah, V. Youngblood, J. Fang, S.Y. Kim, C. Yeung, L.J. Helman, A. Mendoza, V. Ngo, L.M. Staudt, J.S. Wei, C. Khanna, D. Catchpoole, S.J. Qualman, S.M. Hewitt, G. Merlino, S.J. Chanock, and J. Khan Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models J. Clin. Invest. 119 2009 3395 3407
19. A.L. Wu, S. Coulter, C. Liddle, A. Wong, J. Eastham-Anderson, D.M. French, A.S. Peterson, and J. Sonoda FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways PLoS One 6 2011 e17868
20. E.T. Sawey, M. Chanrion, C. Cai, G. Wu, J. Zhang, L. Zender, A. Zhao, R.W. Busuttil, H. Yee, L. Stein, D.M. French, R.S. Finn, S.W. Lowe, and S. Powers Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening Cancer Cell 19 2011 347 358
21. Y.W. Ye, Y. Zhou, L. Yuan, C.M. Wang, C.Y. Du, and X.Y. Zhou et al. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression Cancer. 117 2011 5304 5313
22. D.L. Rimm, R.L. Camp, L.A. Charette, J. Costa, D.A. Olsen, and M. Reiss Tissue microarray: a new technology for amplification of tissue resources Cancer J. 7 2001 24 31
23. S. Ning, S. Guo, J. Xie, Y. Xu, X. Lu, and Y. Chen TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma J. Gastrointest. Surg. 17 2013 360 368
24. S.Q. Li, A.T. Cheuk, J.F. Shern, Y.K. Song, L. Hurd, H. Liao, J.S. Wei, and J. Khan Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534) PLoS One 8 2013 e76551
25. V.T. Bicocca, B.H. Chang, B.K. Masouleh, M. Muschen, M.M. Loriaux, B.J. Druker, and J.W. Tyner Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia Cancer Cell 22 2012 656 667
26. J.Y. Chiang Bile acids: regulation of synthesis J. Lipid Res. 50 2009 1955 1966
27. S. Feng, O. Dakhova, C.J. Creighton, and M. Ittmann Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression Cancer Res. 73 2013 2551 2562
28. V.C. da Costa Andrade, O. Parise Jr., C.P. Hors, P.C. de Melo Martins, A.P. Silva, and B. Garicochea The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma Exp. Mol. Pathol. 82 2007 53 57